OBJECTIVE: To examine essential fatty acids (EFAs) in hyper-IgD syndrome (HIDS) and Familial Mediterranean Fever (FMF). METHODS: EFAs were determined in sera derived from an archival, cross-sectional group of HIDS/FMF patients, stratified for presence and absence of fever. Control populations included healthy afebrile adults, and individuals with non-periodic fever (septic shock). EFAs were quantified using isotope dilution gas chromatography-mass spectrometry and data analyzed employing a Kruskal-Wallis non-parametric ANOVA with Dunn's post-hoc test. RESULTS: Sera samples derived from HIDS patients showed significantly decreased C20, C26, phytanic and pristanic acids during febrile crises that normalized in the afebrile state, and a significantly increased afebrile C22_4ω6 level that normalized with fever. Samples derived from FMF patients revealed increased ω-oxidized LCFAs as compared to controls, and the trend was for these same species to be increased in comparison to febrile, but not afebrile, HIDS patients. Individuals with non-periodic fever demonstrated global decreases in C10-C24 fatty acids, both saturated and unsaturated, accompanied by an elevated triene/tetraene ratio. CONCLUSIONS: Our results suggest that different mechanisms are active in hereditary periodic fever syndromes that appear unrelated to fever, including depletion of very long chain fatty acids (VLCFAs) in febrile HIDS patients and increased ω-oxidized LCFAs in patients with FMF. These findings underscore new roles for EFAs in the potential production of inflammatory species in patients with hereditary periodic fever.
OBJECTIVE: To examine essential fatty acids (EFAs) in hyper-IgD syndrome (HIDS) and Familial Mediterranean Fever (FMF). METHODS:EFAs were determined in sera derived from an archival, cross-sectional group of HIDS/FMFpatients, stratified for presence and absence of fever. Control populations included healthy afebrile adults, and individuals with non-periodic fever (septic shock). EFAs were quantified using isotope dilution gas chromatography-mass spectrometry and data analyzed employing a Kruskal-Wallis non-parametric ANOVA with Dunn's post-hoc test. RESULTS: Sera samples derived from HIDSpatients showed significantly decreased C20, C26, phytanic and pristanic acids during febrile crises that normalized in the afebrile state, and a significantly increased afebrile C22_4ω6 level that normalized with fever. Samples derived from FMFpatients revealed increased ω-oxidized LCFAs as compared to controls, and the trend was for these same species to be increased in comparison to febrile, but not afebrile, HIDSpatients. Individuals with non-periodic fever demonstrated global decreases in C10-C24 fatty acids, both saturated and unsaturated, accompanied by an elevated triene/tetraene ratio. CONCLUSIONS: Our results suggest that different mechanisms are active in hereditary periodic fever syndromes that appear unrelated to fever, including depletion of very long chain fatty acids (VLCFAs) in febrile HIDSpatients and increased ω-oxidized LCFAs in patients with FMF. These findings underscore new roles for EFAs in the potential production of inflammatory species in patients with hereditary periodic fever.
Authors: Joost Frenkel; Ger T Rijkers; Saskia H L Mandey; Sandra W M Buurman; Sander M Houten; Ronald J A Wanders; Hans R Waterham; Wietse Kuis Journal: Arthritis Rheum Date: 2002-10
Authors: Sander M Houten; Joost Frenkel; Ger T Rijkers; Ronald J A Wanders; Wietse Kuis; Hans R Waterham Journal: Hum Mol Genet Date: 2002-12-01 Impact factor: 6.150
Authors: Susanna S T Lee; Wood-Yee Chan; Cherry K C Lo; David C C Wan; David S C Tsang; Wing-Tai Cheung Journal: J Lipid Res Date: 2004-09-01 Impact factor: 5.922
Authors: Viola Prietsch; Ertan Mayatepek; Hermann Krastel; Dorothea Haas; Dorothee Zundel; Hans R Waterham; Ronald J A Wanders; K Michael Gibson; Georg F Hoffmann Journal: Pediatrics Date: 2003-02 Impact factor: 7.124
Authors: Cora Weigert; Katrin Brodbeck; Harald Staiger; Christiana Kausch; Fausto Machicao; Hans U Häring; Erwin D Schleicher Journal: J Biol Chem Date: 2004-03-17 Impact factor: 5.157
Authors: Karam R Motawea; Omneya A Kandil; Joseph Varney; Merna Aboelenein; Nancy Ibrahim; Ahmed Shaheen; Lina T Khairy; Agyad Bakkour; Ali H H Muwaili; Dhuha H H Muwaili; Fatima A A Abdelmajid; Eman M S Ahmad; Mhd K Albuni; Elias Battikh; Bisher Sawaf; Sarya Swed; Safaa M A Ahmed; Dina M Awad; Jaffer Shah; Hani Aiash Journal: Health Sci Rep Date: 2022-06-13